Cholestatic Drug-induced Liver Injury
Condition(s):Hepatitis, ToxicLast Updated:June 10, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatitis, ToxicLast Updated:June 10, 2010Unknown status
Condition(s):Arthritis; Systemic Lupus Erythematosus; Rheumatoid Arthritis; Capillary Leak Syndrome; HepatitisLast Updated:September 4, 2019Completed
Condition(s):Lymphocytic Myocarditis (Disorder); Heart Failure; Dilated Cardiomyopathy; Cardiomyopathies; Sudden Cardiac DeathLast Updated:February 14, 2022Unknown status
Condition(s):Primary Hypercholesterolemia; DyslipidemiaLast Updated:August 16, 2018Terminated
Condition(s):Primary Hypercholesterolemia; Mixed DyslipidemiaLast Updated:February 6, 2019Completed
Condition(s):Mixed HyperlipidemiaLast Updated:August 31, 2018Completed
Condition(s):Lung Cancer Stage IV; Lung Cancer, Non-small Cell; HepatitisLast Updated:January 21, 2022Recruiting
Condition(s):Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected SubjectsLast Updated:August 5, 2015Completed
Condition(s):Hepatitis; PharmacologyLast Updated:March 27, 2024Recruiting
Condition(s):HIV Infections; Liver Toxicity; Hepatitis Co-infectionLast Updated:January 10, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.